Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by AKAMPION
< Previous
1
2
3
Next >
New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe
January 31, 2024
From
AKAMPION
Via
GlobeNewswire
selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024
January 05, 2024
From
AKAMPION
Via
GlobeNewswire
1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors
December 14, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023
December 11, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board
December 05, 2023
From
AKAMPION
Via
GlobeNewswire
EBViously Presents Novel In-Vitro Data Demonstrating Potent Infection Prevention of its Vaccine Candidate EBV-001
December 04, 2023
From
AKAMPION
Via
GlobeNewswire
Ebenbuild to Receive Public Funding Under UBIC Consortium for Digital Lung Twin Project
November 28, 2023
From
AKAMPION
Via
GlobeNewswire
Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its Next-Generation Anti-Infective OMN6
November 20, 2023
From
AKAMPION
Via
GlobeNewswire
Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
November 01, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Presents Novel Production Workflow for Customized, 3D-Printed Bone Scaffolds
October 30, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002
October 24, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
October 17, 2023
From
AKAMPION
Via
GlobeNewswire
Dopavision Reports Successful Completion of Enrollment for MyopiaX-1 Trial
September 26, 2023
From
AKAMPION
Via
GlobeNewswire
Cellbox Solutions Submits Device Master File (DMF) to the U.S. FDA
September 25, 2023
From
AKAMPION
Via
GlobeNewswire
1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab)
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Establishes High-Profile Clinical Advisory Board
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Appoints Dr. Constanze Guenther as Senior Vice President, CMC and Technical Development
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Reports Positive One-Year Patient Follow-Up Data for Resorbable Breast and Pectus Excavatum Scaffolds
September 05, 2023
From
AKAMPION
Via
GlobeNewswire
TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing
July 06, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Granted Market Access in Europe for Custom-Made Bone and Pectus Excavatum Scaffolds
July 06, 2023
From
AKAMPION
Via
GlobeNewswire
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
July 05, 2023
From
AKAMPION
Via
GlobeNewswire
Oliver Healthcare Packaging Strengthens Supply Chain, Adds In-Region Film & Foil Production
June 29, 2023
From
AKAMPION
Via
GlobeNewswire
Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active
June 28, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Demonstrates Superior Biomechanical Properties of its 3-D Printed, Resorbable Scaffolds for Bone Reconstruction
June 20, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment
June 20, 2023
From
AKAMPION
Via
GlobeNewswire
MetrioPharm Receives Orphan Drug Designation for the Treatment of Duchenne Muscular Dystrophy
May 30, 2023
From
AKAMPION
Via
GlobeNewswire
selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis
May 30, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001
May 24, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002
May 24, 2023
From
AKAMPION
Via
GlobeNewswire
Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer
May 12, 2023
From
AKAMPION
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
